Used primarily in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds. Its structure supports the development of kinase inhibitors, which are important in the treatment of cancer and inflammatory diseases. The trifluoromethyl group enhances metabolic stability and binding affinity, making it valuable in optimizing drug candidates. It is also explored in the design of central nervous system agents due to its ability to cross the blood-brain barrier. Additionally, this compound serves as a building block in agrochemicals for developing new pesticides with improved efficacy and environmental profiles.